Hepatocellular Carcinoma: Epidemiology, Pathogenesis and Treatment
A special issue of Current Oncology (ISSN 1718-7729).
Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 14728
Special Issue Editors
Interests: hepatocellular carcinoma; outcome; diagnosis; immunotherapy; artificial intelligence; lenvatinib; trans-arterial chemoemboilzation; selective internal radiotherapy; microwave ablation; surgery
Special Issues, Collections and Topics in MDPI journals
Interests: hepatocellular carcinoma; cholangiocellular carcinoma
Special Issue Information
Dear Colleagues,
The topic of liver cancer is receiving increasing attention. Hepatocellular carcinomas are still the primary liver cancers, with the highest prevalence and death toll worldwide. Intrahepatic cholangiocarcinoma is also on the rise, and an ever-increasing number of rare liver cancers are being reported. Epidemiology, pathogenesis, and response to surgical, locoregional, and systemic treatments are all elements of particular interest which need further elucidation by future studies. This Special Issue will cover all aspects, and welcomes both original research and comprehensive review papers to guide a wide readership toward the most recent and ground-breaking research in this complex field.
Dr. Francesco Tovoli
Dr. Luca Ielasi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatocellular carcinoma
- liver cancer
- epidemiology
- pathogenesis
- treatment